[Drug discovery and development of vaccination strategies for the treatment and prevention of cutaneous leishmaniasis].
Schurigt
Uta
U
Institut für Molekulare Infektionsbiologie, Universität Würzburg, Josef-Schneider-Str. 2, D-97080 Würzburg.
Moll
Heidrun
H
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D055808:Drug Discovery; D006801:Humans; D007891:Leishmania / Q000276:immunology; D054332:Leishmaniasis Vaccines / Q000627:therapeutic use*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000469:parasitology*
D000981:Antiprotozoal Agents; D054332:Leishmaniasis Vaccines